Advertisement

Editorial: Neuropalliative care for movement disorders in the time of COVID-19

      In this issue of PRD, Subramanian and Vaughan provide a framework for providing Neuropalliative care to those with Parkinson disease (PD), although this approach could be broadened to those with any movement disorder with global motor and cognitive symptoms [
      • Subramanian I.
      • Vaughan C.
      Hoping for the best, planning for the worst: palliative care approach for Parkinson disease during the COVID-19 pandemic.
      ]. Palliative medicine is a specialty that aims to improve quality of life for people with serious or advanced medical conditions by assessing and managing symptoms, establishing goals of care, providing support to caregivers, and engaging in advance care planning discussions [
      World health Organization
      Who definition of palliative care.
      ]. It is a complementary approach to care that can be provided while patients are receiving their usual medical care. Neuropalliative care is an emerging subspecialty that offers a relatively new approach to PD and it has much to offer patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Subramanian I.
        • Vaughan C.
        Hoping for the best, planning for the worst: palliative care approach for Parkinson disease during the COVID-19 pandemic.
        Park. Relat. Disord. 2020; (in press)
        • World health Organization
        Who definition of palliative care.
        (Accessed)
        • Miyasaki J.M.
        • Long J.
        • Mancini D.
        • Moro E.
        • Fox S.H.
        • Lang A.E.
        • Marras C.
        • Chen R.
        • Strafella A.
        • Arshinoff R.
        • Ghoche R.
        • Hui J.
        Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD.
        Park. Relat. Disord. 2012; 18: S6-S9
      1. Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS. Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders. A randomized clinical trial. JAMA Neurology doi:10.1001/jamaneurol.2019.4992.

        • Kluger B.M.
        • Vaughan C.L.
        • Robinson M.T.
        • Creutzfeldt C.
        • Subramanian I.
        • Holloway R.G.
        Neuropalliative care essentials for the COVID-19 crisis.
        Neurology. 2020 Sep 1; 95: 394-398
        • Quill T.E.
        • Abernethy A.P.
        Generalist plus specialist palliative care – creating a more sustainable model.
        N. Engl. J. Med. 2013; 368: 1173-1175
        • Tuck K.K.
        • Brod L.
        • Nutt J.
        • Fromme E.K.
        Preferences of patients with Parkinson's disease for communication about advanced care planning.
        J Hospice and Pall Medicine. 2013; 32: 68-77
        • Creutzfeldt C.J.
        • Robinson M.T.
        • Holloway R.G.
        Neurologists as primary palliative care providers: communication and practice approaches.
        Neurol Clin Pract. 2016; 6: 40-48
        • Sleeman K.E.
        • Ho Y.K.
        • Verne J.
        • et al.
        Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: a population-based study.
        Palliat. Med. 2013; 27: 840-846
        • Lum H.D.
        • Jordan S.R.
        • Brungardt A.
        • Ayele R.
        • Katz M.
        • Miyasaki J.M.
        • Hall A.
        • Jones J.
        • Kluger B.
        Neurology. 2019; 92: e2571-e2579https://doi.org/10.1212/WNL.0000000000007552
        • Prizer L.P.
        • Kluger B.M.
        • Sillau S.
        • Katz M.
        • Galifianakis N.B.
        • Miyasaki J.M.
        The presence of a caregiver is associated with patient outcomes in patients with Parkinson's disease and atypical parkinsonisms.
        Park. Relat. Disord. 2020; https://doi.org/10.1016/j.parkreldis.2020.07.003
        • Gerlach O.H.H.
        • Broen M.P.G.
        • Weber W.E.J.
        Motor outcomes during hospitalization in Parkinson's disease patients: a prospective study.
        Park. Relat. Disord. 2013; 19: 737-741